HMVRX | JVMAX | HMVRX / JVMAX | |
Total Expense Ratio | 1.48 | 1.12 | 132% |
Annual Report Gross Expense Ratio | 1.48 | 1.13 | 131% |
Fund Existence | 15 years | 28 years | - |
Gain YTD | 1.844 | 8.143 | 23% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.16B | 22.6B | 5% |
Annual Yield % from dividends | 0.31 | 0.58 | 54% |
Returns for 1 year | -2.17 | 2.13 | -102% |
Returns for 3 years | 4.84 | 22.68 | 21% |
Returns for 5 years | 39.03 | 61.48 | 63% |
Returns for 10 years | 4.78 | 40.93 | 12% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BMED | 25.43 | 0.58 | +2.35% |
iShares Health Innovation Active ETF | |||
VNQ | 89.75 | 0.56 | +0.63% |
Vanguard Real Estate ETF | |||
ISPY | 42.77 | 0.13 | +0.30% |
ProShares S&P 500 High Income ETF | |||
MLPR | 60.50 | 0.04 | +0.06% |
ETRACS Qrtly Py 1.5X Lvgd Aln MLP ETN | |||
NHS | 7.55 | -0.04 | -0.53% |
Neuberger Berman High Yield Strategies Fund |